GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 259 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,364,000 | +28.5% | 105,305 | +39.3% | 0.02% | +72.7% |
Q1 2022 | $2,618,000 | +106.0% | 75,578 | +74.0% | 0.01% | +266.7% |
Q4 2021 | $1,271,000 | -3.7% | 43,430 | -16.2% | 0.00% | -25.0% |
Q3 2021 | $1,320,000 | +182.7% | 51,804 | +288.6% | 0.00% | +100.0% |
Q2 2021 | $467,000 | -6.2% | 13,332 | +9.0% | 0.00% | -33.3% |
Q1 2021 | $498,000 | -32.4% | 12,230 | -28.1% | 0.00% | -40.0% |
Q4 2020 | $737,000 | +114.2% | 17,019 | +172.4% | 0.01% | 0.0% |
Q3 2020 | $344,000 | -88.3% | 6,247 | -86.6% | 0.01% | -89.6% |
Q2 2020 | $2,941,000 | +492.9% | 46,591 | +379.7% | 0.05% | +269.2% |
Q1 2020 | $496,000 | -66.6% | 9,713 | -48.0% | 0.01% | +44.4% |
Q4 2019 | $1,486,000 | -50.4% | 18,695 | -69.7% | 0.01% | -66.7% |
Q3 2019 | $2,996,000 | -12.9% | 61,746 | -5.6% | 0.03% | -20.6% |
Q2 2019 | $3,439,000 | +210.9% | 65,383 | +212.8% | 0.03% | +183.3% |
Q1 2019 | $1,106,000 | +78.1% | 20,900 | +38.0% | 0.01% | +71.4% |
Q4 2018 | $621,000 | -39.5% | 15,140 | -43.9% | 0.01% | -41.7% |
Q3 2018 | $1,026,000 | -23.8% | 27,000 | -9.4% | 0.01% | -33.3% |
Q2 2018 | $1,347,000 | +51.5% | 29,800 | +62.0% | 0.02% | +28.6% |
Q1 2018 | $889,000 | -46.1% | 18,400 | -56.1% | 0.01% | -51.7% |
Q4 2017 | $1,649,000 | +19.0% | 41,894 | +11.4% | 0.03% | -23.7% |
Q1 2017 | $1,386,000 | +216.4% | 37,606 | +24.0% | 0.04% | +111.1% |
Q4 2016 | $438,000 | – | 30,330 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |